source
- Danaher partners with Microsoft to create AI-driven scientific instrument platformDanaher Corp announced a strategic partnership with Microsoft to develop smart scientific instruments and an interoperable ecosystem for laboratories. The collaboration will combine Danaher’s expe…
- Merck’s TROP2 ADC extends survival in pivotal gastroesophageal cancer trialMerck & Co.’s sacituzumab tirumotecan has improved overall survival in a phase 3 cancer trial, delivering a second pivotal global victory for the TROP2-directed antibody-drug conjugate.